Table II.
Study | Design | Participants | Intervention | Control | Outcomes |
---|---|---|---|---|---|
Gleicher et al (2011) | Case report | 4 | Intrauterine infusion of 30×106 IU (300 µg/1 mL) of rG-CSF performed for 6-12 hr before hCG injection | - | - |
Gleicher et al (2013) | Prospective observational cohort | 21 in vitro fertilization patients women with endometrium <7 mm on the day of hCG administration | Intrauterine infusion of 30×106 IU (300 µg/1 mL) of rG-CSF performed for 6-12 hr before hCG injection | Did not include a control group | Endometrial thickness |
Barad et al (2014) |
Prospective randomized cohort | 141 normal in vitro fertilization patients (73 rG-CSF group and 68 placebo group) | Intrauterine infusion of 30×106 IU (300 µg/1 mL) of rG-CSF performed for 6-12 hr before hCG injection | Intrauterine infusion of saline solution | Endometrial thickness Implantation rate Clinical pregnancy rate |
Li et al (2014) |
Retrospective observational cohort | 59 patients submitted to frozen embryo transfer (34 rG-CSF group and 25 no treated group) | Intrauterine infusion of 100 µg/0.6 mL of rG-CSF | No treatment | Implantation rate Clinical pregnancy rate |
Kunicki et al (2014) | Retrospective observational cohort | 37 in vitro fertilization patients with endometrium <7 mm on the day of hCG administration | Intrauterine infusion of 30×106 IU (300 µg/1 mL) of rG-CSF | Did not include a control group | Endometrial thickness |
G-CSF: granulocyte colony-stimulating factor
hCG: human chorionic gonadotropin.